Skip to Content

New Drug Approvals Archive - February 2003

February 2003

Cardizem LA (diltiazem hydrochloride) Extended-Release Tablets

Date of Approval: February 6, 2003
Company: Biovail Laboratories Incorporated
Treatment for: Hypertension, Angina Pectoris

Cardizem LA is an extended-release formulation of diltiazem for indicated for the once-daily treatment of hypertension and for the management of chronic stable angina.

Oxytrol (oxybutynin) Transdermal System

Date of Approval: February 26, 2003
Company: Allergan, Inc.
Treatment for: Overactive Bladder

Oxytrol (oxybutynin) is a transdermal therapy used to treat overactive bladder (OAB), with symptoms of urge urinary incontinence, urgency and frequency.

New Drug Approvals Archive

More News Resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.